Alimera Sciences, Inc. (ALIM) earnings
Quarterly and annual ALIM reports and results, each read against the price at its own news timestamp. Back to the ALIM overview →
9 measured ALIM earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ALIMERA SCIENCES INC For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.36% | |
| Alimera Sciences Reports Second Quarter 2024 Results | Press release | +0.18% | +0.18% | |
| Alimera Sciences Reports First Quarter 2024 Results | Press release | -4.41% | -3.53% | |
| Form 10-Q ALIMERA SCIENCES INC For: Mar 31 | SEC filing · Form 10-Q | +0.92% | -0.30% | |
| Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update | Press release | — | +1.66% | |
| Form 10-K/A ALIMERA SCIENCES INC For: Dec 31 | SEC filing · Form 10-K | — | +1.66% | |
| Form 10-K ALIMERA SCIENCES INC For: Dec 31 | SEC filing · Form 10-K | -2.77% | -5.04% | |
| Form 10-Q ALIMERA SCIENCES INC For: Sep 30 | SEC filing · Form 10-Q | — | +0.31% | |
| Alimera Sciences Reports Third Quarter 2023 Results | Press release | -0.99% | +7.07% |
Keep exploring
More ALIM: analyst actions → · SEC filings → · ALIM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Nutriband Inc. (NTRB) | 143 | 0.00% | 44% |
| Redhill Biopharma Ltd. - American Depositary Shares (RDHL) | 143 | -0.50% | 39% |
| G1 Therapeutics, Inc. (GTHX) | 142 | +0.21% | 66% |
| InflaRx N.V. (IFRX) | 142 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.